Julie Ishida, MD

TitleAssistant Professor
SchoolUCSF School of Medicine
Address521 Parnassus Avenue
San Francisco CA 94117
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, BerkeleyB.A.2001Molecular and Cell Biology/Biochemistry
    Stanford UniversityM.D.2007Medicine
    University of California, San FranciscoM.A.S. in Clinical Research2013Epidemiology & Biostatistics
    University of California, San FranciscoResidencyInternal Medicine
    University of California, San FranciscoFellowshipNephrology
    Collapse Awards and Honors
    UC Berkeley2001Phi Beta Kappa
    UC Berkeley2001Highest Distinction (equivalent to summa cum laude)
    University of California, San Francisco2005  - 2006Doris Duke Charitable Foundation Clinical Research Fellowship
    American Association for the Study of Liver Diseases2006Presidential Poster of Distinction
    American Society of Nephrology2011Pragmatic Clinical Trials Early Program Travel Support
    American Society of Nephrology 2012  - 2014American Society of Nephrology Research Fellowship
    National Institute of Diabetes and Digestive and Kidney Diseases2015  - 2020Mentored Patient-Oriented Research Career Development Award (K23)

    Collapse Overview 
    Collapse Overview
    College: University of California, Berkeley, BA in Molecular and Cell Biology/Biochemistry
    Medical school: Stanford University, MD
    Other graduate training: University of California, San Francisco, MAS in Clinical Research
    Internal medicine residency: University of California, San Francisco
    Nephrology fellowship: University of California, San Francisco

    Dr. Ishida is establishing herself as a young investigator in patient-oriented clinical research aimed at improving the quality of medication prescribing for patients with kidney disease. Her work to date includes studies pertaining to medication safety in hemodialysis patients, and she is now focused on the development of a digital tool to optimize the prescription of analgesics in hemodialysis patients. Her long-term goal is to develop, implement and evaluate strategies to promote the appropriate use of medications, including analgesics, in patients with chronic kidney disease requiring and not requiring dialysis.

    Collapse Research 
    Collapse Research Activities and Funding
    Facilitating Appropriate Analgesic Prescription in Hemodialysis Patients
    NIH K23DK103963Aug 1, 2015 - May 31, 2020
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kaysen GA, Grimes B, Dalrymple LS, Chertow GM, Ishida JH, Delgado C, Segal M, Chiang J, Dwyer T, Johansen KL. Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. J Clin Lipidol. 2018 Mar - Apr; 12(2):481-487.e14. PMID: 29361496.
      View in: PubMed
    2. Ishida JH, Auer R, Vittinghoff E, Pletcher MJ, Reis JP, Sidney S, Johansen KL, Bibbins-Domingo K, Peralta CA, Shlipak MG. Marijuana Use and Estimated Glomerular Filtration Rate in Young Adults. Clin J Am Soc Nephrol. 2017 Oct 06; 12(10):1578-1587. PMID: 28838990.
      View in: PubMed
    3. Ishida JH, Patel A, Mehta AK, Gatault P, McBride JM, Burgess T, Derby MA, Snydman DR, Emu B, Feierbach B, Fouts AE, Maia M, Deng R, Rosenberger CM, Gennaro LA, Striano NS, Liao XC, Tavel JA. Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. Antimicrob Agents Chemother. 2017 02; 61(2). PMID: 27872061.
      View in: PubMed
    4. Ishida JH, Johansen KL. Exclusion of Patients With Kidney Disease From Cardiovascular Trials. JAMA Intern Med. 2016 Jan; 176(1):124-5. PMID: 26618994; PMCID: PMC4701578 [Available on 01/01/17].
    5. Ishida JH, Marafino BJ, McCulloch CE, Dalrymple LS, Dudley RA, Grimes BA, Johansen KL. Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection. Clin J Am Soc Nephrol. 2015 Oct 07; 10(10):1799-805. PMID: 26416943; PMCID: PMC4594059 [Available on 10/07/16].
    6. Ishida JH, Burgess T, Derby MA, Brown PA, Maia M, Deng R, Emu B, Feierbach B, Fouts AE, Liao XC, Tavel JA. Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults. Antimicrob Agents Chemother. 2015 Aug; 59(8):4919-29. PMID: 26055360; PMCID: PMC4505204.
    7. Ishida J, Marafino B, McCulloch CE, Dalrymple LS, Dudley RA, Grimes BA, Johansen KL. J Am Soc Nephrol. Association between Intravenous Iron Receipt and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection (Oral presentation at American Society of Nephrology Annual Meeting 2014). 2014; 25:55A.
    8. Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida JH, Grimes B, Kaysen GA, Nguyen DV. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014 Jan; 9(1):73-81. PMID: 24370770; PMCID: PMC3878699.
    9. Ishida JH, Johansen KL. Iron and infection in hemodialysis patients. Semin Dial. 2014 Jan-Feb; 27(1):26-36. PMID: 24329610; PMCID: PMC4016233.
    10. Dalrymple LS, Johansen KL, Romano PS, Chertow GM, Mu Y, Ishida J, Grimes BA, Kaysen G, Nguyen DV. J Am Soc Nephrol. Comparison of Hospitalization between For-Profit and Nonprofit Dialysis Facilities (Oral presentation at American Society of Nephrology Annual Meeting 2013). 2013; 24:29A.
    11. Ishida JH, McCulloch CE, Dudley RA, Grimes BA, Johansen KL. Dialysis facility profit status and compliance with a black box warning. JAMA Intern Med. 2013 Jun 24; 173(12):1152-3. PMID: 23699967; PMCID: PMC4778550.
    12. Ishida J, McCulloch CE, Dudley RA, Grimes BA, Johansen KL. J Am Soc Nephrol. Change in Erythropoiesis-Stimulating Agent Dosage in For-profit versus Non-profit Dialysis Facilities after a Black Box Warning (Poster presentation at American Society of Nephrology Annual Meeting 2012). 2012; 23:420A.
    13. Ishida JH, Peters MG, Jin C, Louie K, Tan V, Bacchetti P, Terrault NA. Influence of cannabis use on severity of hepatitis C disease. Clin Gastroenterol Hepatol. 2008 Jan; 6(1):69-75. PMID: 18166478; PMCID: PMC3184401.
    14. Ishida J, Jin C, Bacchetti P, Tan V, Peters MG, Terrault NA. Hepatology. Influence of Cannabis Use on Severity of Hepatitis C Disease (Poster presentation at American Association for the Study of Liver Diseases Annual Meeting 2006). 2006; 44(S1):268A.
    Julie's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP